Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders

OBJECTIVES: People suffering from mental health disorder (MHDs) are often under-represented in clinical research though the reasons for their exclusion are rarely recorded. As they have higher rates of smoking and nicotine dependence, it is crucial that they are adequately represented in clinical tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Talukder, Saki Rubaiya, Lappin, Julia M, Boland, Veronica, McRobbie, Hayden, Courtney, Ryan James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314072/
https://www.ncbi.nlm.nih.gov/pubmed/34862325
http://dx.doi.org/10.1136/tobaccocontrol-2021-056843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314072/
https://www.ncbi.nlm.nih.gov/pubmed/34862325
http://dx.doi.org/10.1136/tobaccocontrol-2021-056843

Ejemplares similares